Glutamate and GABA in Microglia-Neuron Cross-Talk in Alzheimer's Disease

Int J Mol Sci. 2021 Oct 28;22(21):11677. doi: 10.3390/ijms222111677.

Abstract

The physiological balance between excitation and inhibition in the brain is significantly affected in Alzheimer's disease (AD). Several neuroactive compounds and their signaling pathways through various types of receptors are crucial in brain homeostasis, among them glutamate and γ-aminobutyric acid (GABA). Activation of microglial receptors regulates the immunological response of these cells, which in AD could be neuroprotective or neurotoxic. The novel research approaches revealed the complexity of microglial function, including the interplay with other cells during neuroinflammation and in the AD brain. The purpose of this review is to describe the role of several proteins and multiple receptors on microglia and neurons, and their involvement in a communication network between cells that could lead to different metabolic loops and cell death/survival. Our review is focused on the role of glutamatergic, GABAergic signaling in microglia-neuronal cross-talk in AD and neuroinflammation. Moreover, the significance of AD-related neurotoxic proteins in glutamate/GABA-mediated dialogue between microglia and neurons was analyzed in search of novel targets in neuroprotection, and advanced pharmacological approaches.

Keywords: Alzheimer’s disease; GABA; glutamate; microglia; neurodegeneration; neuroinflammation; neurons; neurotransmission; signaling; therapeutic approaches.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / metabolism*
  • Amyloid beta-Peptides / metabolism
  • Animals
  • Brain / metabolism*
  • Glutamic Acid / metabolism*
  • Humans
  • Microglia / metabolism*
  • Neuroinflammatory Diseases / metabolism
  • Neurons / metabolism*
  • Receptor Cross-Talk
  • gamma-Aminobutyric Acid / metabolism*

Substances

  • Amyloid beta-Peptides
  • Glutamic Acid
  • gamma-Aminobutyric Acid